RAYMOND JAMES & ASSOCIATES - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 242 filers reported holding TRANSMEDICS GROUP INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2024$3,531,135
+414.2%
23,444
+152.4%
0.00%
Q1 2024$686,755
+89.4%
9,288
+102.2%
0.00%
Q4 2023$362,525
+76.9%
4,593
+22.7%
0.00%
Q3 2023$204,875
-58.1%
3,742
-35.7%
0.00%
Q2 2023$488,848
-68.2%
5,821
-71.3%
0.00%
-100.0%
Q1 2023$1,535,653
+246.3%
20,278
+182.3%
0.00%
Q4 2022$443,396
+94.5%
7,184
+31.2%
0.00%
Q3 2022$228,000
-36.1%
5,474
-36.3%
0.00%
Q1 2021$357,0008,5950.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2023
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders